Global seroprevalence and sociodemographic characteristics ofBorrelia burgdorferi sensu latoin human populations: a systematic review and meta-analysis

Abstract

IntroductionBorrelia burgdorferi sensu lato (Bb) infection, the most frequent tick-transmitted disease, is distributed worldwide. This study aimed to describe the global seroprevalence and sociodemographic characteristics of Bb in human populations.MethodsWe searched PubMed, Embase, Web of Science and other sources for relevant studies of all study designs through 30 December 2021 with the following keywords: ‘Borrelia burgdorferi sensu lato’ AND ‘infection rate’; and observational studies were included if the results of human Bb antibody seroprevalence surveys were reported, the laboratory serological detection method reported and be published in a peer-reviewed journal. We screened titles/abstracts and full texts of papers and appraised the risk of bias using the Cochrane Collaboration-endorsed Newcastle-Ottawa Quality Assessment Scale. Data were synthesised narratively, stratified by different types of outcomes. We also conducted random effects meta-analysis where we had a minimum of two studies with 95% CIs reported. The study protocol has been registered with PROSPERO (CRD42021261362).ResultsOf 4196 studies, 137 were eligible for full-text screening, and 89 (158 287 individuals) were included in meta-analyses. The reported estimated global Bb seroprevalence was 14.5% (95% CI 12.8% to 16.3%), and the top three regions of Bb seroprevalence were Central Europe (20.7%, 95% CI 13.8% to 28.6%), Eastern Asia (15.9%, 95% CI 6.6% to 28.3%) and Western Europe (13.5%, 95% CI 9.5% to 18.0%). Meta-regression analysis showed that after eliminating confounding risk factors, the methods lacked western blotting (WB) confirmation and increased the risk of false-positive Bb antibody detection compared with the methods using WB confirmation (OR 1.9, 95% CI 1.6 to 2.2). Other factors associated with Bb seropositivity include age ≥50 years (12.6%, 95% CI 8.0% to 18.1%), men (7.8%, 95% CI 4.6% to 11.9%), residence of rural area (8.4%, 95% CI 5.0% to 12.6%) and suffering tick bites (18.8%, 95% CI 10.1% to 29.4%).ConclusionThe reported estimated global Bb seropositivity is relatively high, with the top three regions as Central Europe, Western Europe and Eastern Asia. Using the WB to confirm Bb serological results could significantly improve the accuracy. More studies are needed to improve the accuracy of global Lyme borreliosis burden estimates.PROSPERO registration numberCRD42021261362.

Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review

“…Only two persister drug regimens presently exist for the treatment of CLD/PTLDS, dapsone combination therapy and disulfiram, with two potential new treatments on the horizon, Azlocillin and Hygromycin A [ 152 , 153 ], both which require clinical evaluation. Since there is no established safe and effective cure for babesiosis and Bartonellosis, both important co-infections in our patients and in the chronic LD population [ 66 ], and no recent randomized clinical trials for Lyme disease in over a decade, it is essential that governmental agencies, university-based researchers, and clinicians in the field come together to help find cures for these diseases, as the burden of individuals that are exposed to Lyme disease and associated tick-borne infections continues to increase every year [ 154 ] with recent studies reporting an estimated global Borrelia burgdorferi sensu lato seroprevalence being 14.5% [ 155 ].…”

How COVID-19 Brought Medical Gaslighting to the Forefront and Made Invisible Illness Visible: Lessons from the BIPOC Long COVID Study

“…Nor were we thinking about the 2-4% of people around the globe with fibromyalgia [37]. Or the estimated 14% of the global population that has had Lyme disease [38], or the estimated five million people around the world with Lupus [39]. All four of these illnesses are chronic conditions that disrupt the immune system and are similar to long COVID [40][41][42][43].…”

Electrochemical Detection of Borrelia burgdorferi Using a Biomimetic Flow Cell System

“…Lyme disease, or Lyme borreliosis, a term which indicates the causative agent, is the most prevalent tickborne illness in both North America and Europe, with an estimated 470,000 cases diagnosed each year in the United States alone. , Lyme disease can be caused by several pathogenic bacterial species within the Borrelia genus, but Borrelia burgdorferi is the primary infectious agent within North America. These bacteria are spread by ticks of the Ixodes genus, hard-bodied ticks common to many temperate regions of the world.…”